will medicaid cover glp 1 for weight loss McKee's proposed FY2027 budget drops GLP-1 drugs from • Rhode Island Current Medicaid now covers GLP-1s for

334-OR: Pemvidutide (ALT-801), a Balanced (1:1) GLP-1/Glucagon dual receptor agonist, induces rapid and marked weight loss without the need for dose titration in people with overweight/obesity

Side effects may resurface briefly with each dose increase but typically resolve faster than during initial titration

The microdose program typically starts at a very low dose of 0.2 mg per week , with the ability to adjust up to a maximum of 0.6 mg if needed

Both drugs commonly cause nausea, vomiting, and diarrhea

In other GLP-1 medications like Ozempic, Trulicity, or Victoza, fatigue is less frequently reported or not specifically listed as a common side effect in FDA prescribing information

We will examine their mechanisms of action within the CNS, their influence on inflammation and neuroprotection, and their potential to support weight reduction in the context of IIH and migraines